Factors influencing the ability of HDL to inhibit expression of vascular cell adhesion molecule-1 in endothelial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 9, 1998, Pages 1450-1455

  Ashby, Dale T ^a   Rye, Kerry Anne ^b   Clay, Moira A ^a   Vadas, Mathew A ^c   Gamble, Jennifer R ^c   Barter, Philip J ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

Atherosclerosis; Endothelial cells; HDL; HDL subfractions; Vascular cell adhesion molecule 1

Indexed keywords

HIGH DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ATHEROGENESIS; ENDOTHELIUM CELL; FOAM CELL; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; LIPID COMPOSITION; LIPOPROTEIN METABOLISM; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; RISK FACTOR; VASCULAR ENDOTHELIUM;

EID: 0031666749     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.9.1450     Document Type: Article

References (25)

1. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary artery disease: the Framingham Study. Am J Med. 1977;62:707-714.
2. Miyazaki A, Rahim ATMA, Ohta T, Morino Y, Horiuchi S. High density lipoprotein mediates selective reduction in cholesterol esters from macrophage foam cells. Biochim Biophys Acta. 1992;1126:73-80.
3. Parthasarathy S, Barnett J, Fong DS. High density lipoprotein inhibits the oxidative modification of low density lipoprotein. Biochim Biophys Acta. 1990;1044:275-283.
4. Cockerill GW, Rye K-A, Gamble JR, Vadas MA, Barter PJ. High density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol. 1995;15:1987-1994.
5. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
6. Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J. 1994;8:504-512.
7. Pober JS, Gimbrone MJ, Lapierre LA, Mendrick DL, Fiers W, Rothlein R, Springer TA. Overlapping patterns of activation of human endothelial cells by interleukin-1, tumour necrosis factor and immune interferon. J Immunol. 1986;137:1893-1896.
8. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a monocyte leukocyte adhesion molecule during atherogenesis. Science. 1991;251:788-791.
9. Van der Wal AC, Das PK, Tigges AJ, Becker AE. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol. 1992;141:161-168.
10. Karlheinz P, Nawroth P, Conradt C, Nordt T, Weiss T, Boehme M, Wunsch A, Allenberg J, Kubler W, Bode C. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol. 1997;17:505-512.
11. Rye K-A. Interaction of the high density lipoprotein conversion factor with recombinant discoidal complexes of egg phosphatidylcholine, free cholesterol and apolipoprotein A-I. J Lipid Res. 1989;30:335-346.
12. Hopkins GJ, Barter PJ. Apolipoprotein A-I inhibits transformation of high density lipoprotein subpopulations during incubation of human plasma. Atherosclerosis. 1989;75:73-82.
13. Osborne JC. Delipidation of plasma lipoproteins. Methods Enzymol. 1986;128A:213-222.
14. Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1956;226:497-509.
15. Sparks DL, Davidson WS, Lund-Katz S, Phillips MC. Effects of the neutral lipid content of high density lipoprotein on apolipoprotein A-I structure and particle stability. J Biol Chem. 1995;270:26910-26917.
16. Rye K-A, Barter PJ. The influence of apolipoproteins on the structure and function of spheroidal, reconstituted high density lipoproteins. J Biol Chem. 1994;269:10298-10303.
17. Matz CE, Jonas A. Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J Biol Chem. 1982;257:4535-4540.
18. Wall RT, Harker LA, Quadracci LJ, Striker GE. Factors influencing endothelial cell proliferation in vitro. J Cell Physiol. 1978;96:203-213.
19. Barter PJ, Rye K-A. High density lipoproteins and coronary heart disease. Atherosclerosis. 1996;121:1-12.
20. Cheung M, Albers JJ. Characterization of lipoprotein particles by immunoaffinity chromatography: particles containing A-I and A-II and particles containing A-I but no A-II. J Biol Chem. 1984;259:12201-12209.
21. Barter PJ, Hopkins GJ, Gorjatschko L. Lipoprotein substrates for plasma cholesterol esterification: influence of particle size and composition of the high density lipoprotein subfraction-3. Atherosclerosis. 1985;58:97-107.
22. 2 phospholipids and triglycerides by hepatic lipase. Biochem Biophys Res Commun. 1981;100:591-599.
23. Marui N, Offermann MK, Swerlick R, Kunsch C, Rosen CA, Ahmad M, Alexander RW, Medford RM. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J Clin Invest. 1993;92:1866-1874.
24. Matsubara T, Ziff M. Increased superoxide anion release from human endothelial cells in response to cytokines. J Immunol. 1986;137:3295-3298.
25. Calabresi L, Franceschini G, Sirtori CR, De Palma A, Saresella M, Ferrante P, Taramelli D. Inhibition of VCAM-I expression in endothelial cells by reconstituted high density lipoproteins. Biochem Biophys Res Commun. 1997;238:61-65.